A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid Tumor
Status:
Active, not recruiting
Trial end date:
2024-04-13
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, open-label, phase Ib study to evaluate the safety,
efficacy and pharmacokinetic characteristics of Mitoxantrone Hydrochloride Liposome in
subjects with advanced solid tumor.